T cell major histocompatibility complex class II molecules down-regulate CD4(+) T cell clone responses following LAG-3 binding

被引:117
作者
Huard, B [1 ]
Prigent, P [1 ]
Pages, F [1 ]
Bruniquel, D [1 ]
Triebel, F [1 ]
机构
[1] INST GUSTAVE ROUSSY,INSERM U333,LAB IMMUNOL CELLULAIRE,F-94805 VILLEJUIF,FRANCE
关键词
T cell; major histocompatibility complex class II; activation gene; CD4; LAG3;
D O I
10.1002/eji.1830260533
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell response to its antigen requires recognition by the T cell receptor together with a co-receptor molecule, either CD4 or CD8. Additional molecules have been identified that are capable of delivering the co-stimulatory signals provided by APC. Following T cell priming, a number of T cell activation antigens are expressed that may play a role in the inactivation phase of the T cell response. The lymphocyte activation gene (LAG)-3 protein and its counter-receptors, the major histocompatibility complex (MHC) class II molecules, are such activation antigens whose interaction may result in the down-regulation of the ongoing immune response. To investigate the role of LAG-3/class II molecule interaction, we produced a soluble form of LAG-3 by fusing the extracellular Ig domains of this membrane protein to the constant region of human IgG1 (LAG-3Ig). Here, we show a direct and specific binding of LAG-3Ig to class II molecules on the cell surface. In addition, we show that LAG-3/class II molecule interaction leads to the down-regulation of CD4(+) Ag-specific T cell clone proliferation and cytokine secretion. This inhibitory effect is observed at the level of the effector cells and not the APC and is also found with anti-CDS mAb, PHA + PMA or low-dose IL-2 driven stimulation in the absence of APC. These functional studies indicate that T cell MHC class II molecules down-regulate T cell proliferation following LAG-3 binding and suggest a role for LAG-3 in the control of the CD4(+) T cell response .
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 19 条
[1]   CHARACTERIZATION OF THE LYMPHOCYTE-ACTIVATION GENE 3-ENCODED PROTEIN - A NEW LIGAND FOR HUMAN-LEUKOCYTE ANTIGEN CLASS-II ANTIGENS [J].
BAIXERAS, E ;
HUARD, B ;
MIOSSEC, C ;
JITSUKAWA, S ;
MARTIN, M ;
HERCEND, T ;
AUFFRAY, C ;
TRIEBEL, F ;
PIATIERTONNEAU, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :327-337
[2]   IDENTIFICATION OF A CD4 BINDING-SITE ON THE BETA-2-DOMAIN OF HLA-DR MOLECULES [J].
CAMMAROTA, G ;
SCHEIRLE, A ;
TAKACS, B ;
DORAN, DM ;
KNORR, R ;
BANNWARTH, W ;
GUARDIOLA, J ;
SINIGAGLIA, F .
NATURE, 1992, 356 (6372) :799-801
[3]   ADHESION RECEPTORS IN LYMPHOCYTE-ACTIVATION [J].
COLLINS, TL ;
KASSNER, PD ;
BIERER, BE ;
BURAKOFF, SJ .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :385-393
[4]   ACTIVATION OF NAIVE, MEMORY AND EFFECTOR T-CELLS [J].
CROFT, M .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :431-437
[5]   ANTIBODIES AGAINST MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGENS DIRECTLY INHIBIT THE GROWTH OF T-CELLS INFECTED WITH THEILERIA-PARVA WITHOUT AFFECTING THEIR STATE OF ACTIVATION [J].
EICHHORN, M ;
PROSPERO, TD ;
HEUSSLER, VT ;
DOBBELAERE, DAE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :769-776
[6]   ACTIVATION-INDUCED APOPTOSIS IN LYMPHOCYTES [J].
GREEN, DR ;
SCOTT, DW .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :476-487
[7]   RECOMBINANT GLOBULINS - NOVEL RESEARCH TOOLS AND POSSIBLE PHARMACEUTICALS [J].
HOLLENBAUGH, D ;
CHALUPNY, NJ ;
ARUFFO, A .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (02) :216-219
[8]  
HUARD B, 1994, IMMUNOGENETICS, V39, P213
[9]   LYMPHOCYTE-ACTIVATION GENE 3 MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INTERACTION MODULATES THE ANTIGENIC RESPONSE OF CD4(+) T-LYMPHOCYTES [J].
HUARD, B ;
TOURNIER, M ;
HERCEND, T ;
TRIEBEL, F ;
FAURE, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3216-3221
[10]   MHC CLASS-II INTERACTION WITH CD4 MEDIATED BY A REGION ANALOGOUS TO THE MHC CLASS-I BINDING-SITE FOR CD8 [J].
KONIG, R ;
HUANG, LY ;
GERMAIN, RN .
NATURE, 1992, 356 (6372) :796-798